AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
AUSTRALIA'S BIOTA US SUBSIDIARY MAKES HIV/AIDS DRUG BREAKTHROUGH.
MELBOURNE, May 1 Asia Pulse - Biota Holdings Ltd (ASX:BTA) shares surged yesterday, after the biotech company said its United States subsidiary had made an important breakthrough in the development a new HIV/AIDS drug.
Biota said California-based Biota Inc had used its N-MAX technology to create novel versions of nucleoside drugs called "nucleotide mimics", which had the potential to be more active and less toxic.
Nucleoside drugs are used to treat HIV/AIDS, hepatitis C and cancer.
Biota said the latest achievement involved the discovery and initial testing of a nucleotide mimic of AZT (zidovudine), a leading anti-HIV nucleoside drug.
Biota Inc president and chief scientist Dr Dan Cook presented the research findings at the International Conference on Antiviral Research (ICAR) in Savannah, Georgia, on Monday.
"The AZT-mimic research has been a remarkable success," Biota group chief executive officer Peter Molloy said.
"In less than a year, Dan Cook's scientific team has demonstrated proof-of-concept for the N-MAX technology and ...
- Biota consolidated loss of $8.57 mln for year to June 30 2002.
- News wire article from: Asia Africa Intelligence Wire September 13, 2002 700+ words
...Biota chairman John Grant noted the Biota Inc expenses were consistent with...pleased with the developments at Biota Inc over the last year," Mr Grant...the NMAX technology developed by Dr Dan Cook, Biota Inc's chief scientist." Biota...
- Biota Acquires NuMax Pharma.
- Newspaper article from: Applied Genetics News June 1, 2001 700+ words
...yr. by Eli Lilly. Biota has for some time been...In acquiring NuMAX, Biota achieves both these goals. P. Dan Cook, an experienced pharmaceutical...infectious diseases. P. Dan Cook has been appointed chief science officer of Biota, Inc. "With the...
- Biota Announces HIV Breakthrough.
- Press release article from: PR Newswire April 29, 2003 700+ words
...HIV/AIDS. Dr. Dan Cook, the President and Chief Scientist of Biota Inc, presented the...success," said Biota Group CEO, Peter...less than a year, Dan Cook's scientific team...CONTACT: Dr. Dan Cook, President &...6980, both of Biota Inc Web site: http...
- Biota announces HIV breakthrough.
- News wire article from: Asia Africa Intelligence Wire April 29, 2003 700+ words
...Business NewsBase - Press Release) Biota Inc, the US subsidiary of Biota Holdings Ltd, announced that it had...new drug to combat HIV/AIDS. Dr Dan Cook, the President and Chief Scientist of Biota, presented the findings at the International...
- Biota Forges New Links with the Biomolecular Research Institute
- Press release article from: PR Newswire July 29, 1997 700+ words
...Australia, July 29 /PRNewswire/ -- Biota Holdings Limited (Australia: BTA) today...BRI), that will significantly expand Biota's research portfolio and strengthen its...knowledge gained in the development of Biota's influenza therapeutic. Biota will...
- Biota Secures Global Influenza Partnership With Sankyo.
- Press release article from: PR Newswire October 3, 2003 700+ words
...Australia, Oct. 3 /PRNewswire/ -- Biota Holdings Limited announced today that it...collaboration and license agreement covers Biota's second-generation influenza compounds...treatment. Under the agreement, Sankyo and Biota will cross-license their relevant patents...
- Biota Values Claim Against GSK at A$308 to A$430 Million.
- Press release article from: PR Newswire July 27, 2005 700+ words
...Australia, July 26 /PRNewswire/ -- Biota Holdings Limited announced today its Particulars...GlaxoSmithKline (GSK) for failing to support Biota's influenza drug, Relenza. The damages...Supreme Court in Australia and estimates Biota's losses in the range of A$ 308-430...
- Biota Raises Relenza Claim to A$564 - A$704 Million (US$485 - US$605 Million).
- Press release article from: PR Newswire July 31, 2007 700+ words
...Australia, July 31 /PRNewswire/ -- Biota has filed its updated Particulars of Loss...influenza drug, Relenza, discovered by Biota and licensed to GSK in 1990. The updated...with the Victorian Supreme Court estimates Biota's losses in the range of A$564 million...
- Biota Sues GSK for Failure to Support its Influenza Drug Relenza(TM).
- Press release article from: PR Newswire May 5, 2004 700+ words
Biota Holdings Limited announced today that it had issued a writ in the...great potential, but it was effectively abandoned at birth," said Biota's CEO, Peter Molloy. Biota claims that the product failed not because of any inherent disadvantages...
- Biota Awarded US Government Funding for New Influenza Drug.
- Press release article from: PR Newswire October 1, 2004 700+ words
...Australia, Sept. 30 /PRNewswire/ -- Biota Holdings Limited announced today that the...Institutes of Health (NIH), had awarded Biota a US$5.6 million grant to develop a...of a lethal strain of influenza," said Biota CEO, Peter Molloy. "Biota's new long...
Source: HighBeam Research, AUSTRALIA'S BIOTA US SUBSIDIARY MAKES HIV/AIDS DRUG BREAKTHROUGH.